Profiling the Endocannabinoid Response to Hedonic Eating
- Conditions
- Food PreferencesObesity
- Registration Number
- NCT03113474
- Lead Sponsor
- Wageningen University
- Brief Summary
Study into the endocannabinoid response to consuming a palatable versus a neutral food.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 25
- Healthy (self-report)
- Dutch
- Evaluating one of the used foods as palatable
- Evaluating one of the used foods as neutral
- Hb value between 8.1 and 11.0 mmol/L at screening
- restraint eating
- lack of appetite
- difficulties eating/swallowing
- endocrine disorders
- energy restricted diet two months prior to study
- weight change > 5 kg in two months prior to study
- stomach or bowel disease
- taste or smell disorders (self-report)
- not consuming foods used in the study
- smoking > 1 cigarette per day
- drinking > 21 units alcohol per week
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Endocannainoid levels prior to, during and two hours after eating To assess changes in endocannabinoid plasma levels prior to, during and after eating a palatable versus a neutral food
- Secondary Outcome Measures
Name Time Method Pancreatic polypeptide (pg/ml) prior to, during and two hours after eating To assess changes in pancreatic polypeptide plasma levels prior to, during and after eating a palatable versus a neutral food
Ghrelin (pg/ml) prior to, during and two hours after eating To assess changes in ghrelin plasma levels prior to, during and after eating a palatable versus a neutral food
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.